Subscribe To
relmada and rel-1017: intriguing underlying efficacy in mdd ahead of eventful 2024
Phase 3 trial failures were due to abnormally high placebo responses driven by poor trial design, enrollment, and oversight. REL-1017's underlying eff...
October 13, 2023, 7:50 pm
relmada therapeutics to present new preclinical data on its psilocybin program at aasld the liver meeting® 2023
Low-dose psilocybin generated s tatistically significant reduc tions in liver fat content, plasma glucose levels and body weight gain in a mice model ...
October 11, 2023, 8:31 am
relmada (rlmd) up on positive data for anti-depressant candidate
Relmada's (RLMD) shares rise on long-term efficiency and safety data from the phase III study of its lead candidate REL-1017 to treat patients with ma...
September 21, 2023, 3:02 pm
relmada therapeutics: run up likely into phase 3 results, enhanced by possible interim readout
relmada Therapeutics has provided updates on its phase 3 program of esmethadone (REL-1017) as an adjunc...
September 1, 2023, 6:53 pm
Bragar eagel & squire, p.c. is investigating relmada, arrival, fmc, and viasat and encourages investors to contact the firm
NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...
July 27, 2023, 1:00 am
Bragar eagel & squire, p.c. is investigating waldencast, relmada, doubleverify, and castle and encourages investors to contact the firm
NEW YORK, July 21, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...
July 22, 2023, 1:00 am
Bragar eagel & squire, p.c. is investigating shift4, waldencast, relmada, and doubleverify and encourages investors to contact the firm
NEW YORK, July 16, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...
July 17, 2023, 12:40 am
Bragar eagel & squire, p.c. is investigating seagate, chegg, relmada, and doubleverify and encourages investors to contact the firm
NEW YORK, July 01, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...
July 1, 2023, 6:43 am
Bragar eagel & squire, p.c. is investigating relmada, doubleverify, sanmina, and jinkosolar and encourages investors to contact the firm
NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...
June 26, 2023, 1:00 am
Rlmd investor news: rosen, recognized investor counsel, encourages relmada therapeutics, inc. investors with losses to inquire about securities class action investigation – rlmd
NEW YORK, June 10, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securiti...
June 10, 2023, 8:59 pm
Bragar eagel & squire, p.c. is investigating relmada, bowlero, and integra and encourages investors to contact the firm
NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...
June 5, 2023, 1:00 am
Rosen, respected investor counsel, encourages relmada therapeutics, inc. investors to inquire about securities class action investigation – rlmd
NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities cla...
June 3, 2023, 4:12 pm
Bragar eagel & squire, p.c. is investigating relmada, and sanmina and encourages investors to contact the firm
NEW YORK, May 19, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potenti...
May 20, 2023, 1:00 am
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of relmada therapeutics, inc. – rlmd
NEW YORK, May 12, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of re...
May 12, 2023, 11:46 pm
relmada therapeutics, inc. (rlmd) q1 2023 earnings call transcript
relmada Therapeutics, Inc. (NASDAQ:RLMD ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Comp...
May 12, 2023, 9:10 pm
relmada therapeutics to report first quarter 2023 financial results and host conference call and webcast on may 11, 2023
CORAL GABLES, Fla. , May 8, 2023 /PRNewswire/ -- relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stag...
May 8, 2023, 7:30 am
relmada therapeutics, inc. (rlmd) q4 2022 earnings call transcript
relmada Therapeutics, Inc. (NASDAQ:RLMD ) Q4 2022 Earnings Conference Call March 23, 2023 4:30 PM ET Co...
March 23, 2023, 10:27 pm
relmada therapeutics shares decline 40% on thursday
Shares of relmada Therapeutics Inc. RLMD, -0.95% tumbled about 40% in premarket trading on Thursday, th...
December 8, 2022, 8:39 am
relmada therapeutics, inc. (rlmd) q3 2022 earnings call transcript
relmada Therapeutics, Inc. (NASDAQ:RLMD ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET...
November 12, 2022, 8:33 am
relmada therapeutics, inc.'s (rlmd) ceo sergio traversa on q1 2022 results - earnings call transcript
relmada Therapeutics, Inc. (NASDAQ:RLMD ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Compa...
May 8, 2022, 11:27 am